Skip to Content

Remarkable results in the treatment of patients with relapsed Large B-Cell Lymphoma

Directly from ASH21 we offer you an update from the  ZUMA‑7 study, A Phase 3 Randomized Trial of Axi-Cel Treatment for patients with relapsed large B-Cell Lymphoma. The results are remarkable, Axi-Cel Treatment is one of the new treatments for lymphoma patients that will likely become a new paradigm in the future. In this MEDtalk, Frederik L. Locke sums up the background of the study and presents the convincing results.

Frederick L. Locke

Få adgang

Hvis du er læge, sygeplejerske eller anden sundhedsprofessionel kan du få adgang til hele artiklen ved at oprette en profil på BestPractice Nordic.

Back to top